Alexandre S. Quadros, MD, PhD

Predictive Score for Target Vessel Revascularization after Bare Metal Coronary Stenting

08/01/2008

Carlos A.M. Gottschall , MD, PhD, FSCAI, FIAGS;

Drug-eluting stents (DES) significantly decrease the need for a new target vessel revascularization (TVR) after coronary intervention,1–4 but its widespread use is still limited by cost issues.5,6 DES are currently used in more than 70% of...

Drug-eluting stents (DES)...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

Validation of a Risk Score for Target Vessel Revascularization after Coronary Stent Implantation

12/04/2009

Thais Modkovski , MD;

Rogério Sarmento-Leite , MD, PhD;

Carlos A.M. Gottschall , MD, PhD, FSCAI, FIAGS;

Alexandre S. Quadros , MD, PhD;

Fabiane Diemer , RN;

Dulce Welter , RN;

ABSTRACT: Objective. Our aim was to validate a risk score for new target vessel revascularization (TVR) after bare-metal stent (BMS) implantation. Methods. The risk score was developed in a cohort of patients previously treated with BMS at...

ABSTRACT: Objective. Our aim was...

12/04/2009

Journal of Invasive Cardiology